Clinical trial
Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at…
NCT00033345 · University of Kansas Medical Center, Other · Completed
Key facts
| NCT number | NCT00033345 |
|---|---|
| Title | Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer |
| Official title | Multiple Daily Dose Phase I Safety And Pharmacokinetic Clinical Study Of Indole-3-Carbinol |
| Lead sponsor | University of Kansas Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | Indole-3-carbinol, Placebo |
| Enrollment | 17 |
| Start date | Jan 1, 2002 |
| Primary completion | Jul 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: